
Sign up to save your podcasts
Or


Could a new standard of treatment be on the horizon for patients with HER2 mutated NSCLC? Dr. Edward Garon, a Thoracic Medical Oncologist at UCLA Health, shares key takeaways on non-small cell lung cancer from the ESMO 2021 Congress.
By ReachMD4.5
22 ratings
Could a new standard of treatment be on the horizon for patients with HER2 mutated NSCLC? Dr. Edward Garon, a Thoracic Medical Oncologist at UCLA Health, shares key takeaways on non-small cell lung cancer from the ESMO 2021 Congress.

39 Listeners

10 Listeners

59 Listeners

1,148 Listeners

195 Listeners

45 Listeners

7 Listeners